Abstract:BACKGROUND: The objective of this study was to assess postintervention patency and analyze the predictive factors associated with early and late restenosis after intervention in hemodialysis arteriovenous fistulas (AVF) and arteriovenous grafts (AVG).METHODS: This study retrospectively analyzed 284 hemodialysis patients who underwent percutaneous transluminal angioplasty (PTA) due to AVF and AVG stenosis. A total of 350 PTA procedures were performed. Clinical, anatomical, biochemical, and technical variables were analyzed. Using univariate and multivariate analyses, we assessed the postintervention patency of PTA by follow-up, and identified the predictive factors taking into account competing risks.RESULTS: Postintervention patency rates at 3, 6, 12, and 24 months were 86.5%, 66.4%, 42.6%, and 29.8%, respectively, with a median patency duration of 11±0.71 months. Kaplan-Meier analysis showed that the patency rate of the AVF group (n=271) was dramatically higher than the AVG group (n=79) at 3, 6, and 12 months after PTA, respectively (88.9% vs. 78.5%, 69.0% vs. 57.4%, 48.8% vs. 20.0%, P<0.01). Cox survival analysis revealed that the factors associated with postintervention patency of AVF included age of fistulas, serum albumin (ALB) levels, location of stenoses, lesion length longer than 2 cm, multiple stenoses, and maximal pressure of dilatation lower than 16 atm. In addition, factors related to postintervention patency of AVG included the presence of diabetes and hypertension, and serum ALB.CONCLUSIONS: This study demonstrated that the risk factors associated with postintervention patency of AVF included age of fistulas, lower levels of serum ALB, location of stenoses, lesion length longer than 2 cm, multiple stenoses, and maximal pressure of dilatation lower than 16 atm. In addition, risk factors related to postintervention patency of AVG included the presence of diabetes and lower levels of serum ALB, while the presence of hypertension was found to be a protective factor for reducing patency loss of AVG. Among all these factors, serum ALB and multiple stenoses tended to predict early restenosis, while pressure of dilatation tended to predict late restenosis.

Investigation on the mechanism of p38MAPK in the failure of autogenous arteriovenous fistula caused by stenosis.

Analysis of Factors Influencing Restenosis after Percutaneous Transluminal Angioplasty

Predictors associated with early and late restenosis of arteriovenous fistulas and grafts after percutaneous transluminal angiography

Primary Investigation of the Intervention Therapies to Arteriovenous Fistula Stenosis

Predictive Value of Ultrasound Classification for Autologous Arteriovenous Fistula Stenosis in Short-Term Efficacy of Ultrasound- Guided Percutaneous Transluminal Angioplasty

Ultrasound-guided percutaneous transluminal angioplasty in the treatment of autologous arteriovenous fistula and its prognostic factors

Efficacy of ultrasound-guided percutaneous transluminal angioplasty for arteriovenous fistula stenosis or occlusion at juxta-anastomosis: A 3-year follow-up cohort study

Arteriovenous fistula stenosis in hemodialysis patients is characterized by an increased adventitial fibrosis

Identification and Validation of Hub Genes in the Stenosis of Arteriovenous Fistula

A rat model of autogenous internal arteriovenous fistula and the experimental study on internal fistula stenosis

Patency and factors related to patency after percutaneous transluminal angioplasty for inflow arterial stenosis in native arteriovenous fistula dysfunction: a single-center retrospective study

Factors affecting the primary patency of native arteriovenous fistulas after ultrasound-guided percutaneous transluminal angioplasty

Correlation of expression of MCP-1 on wall of radial artery with stenosis of cannulation site in arteriovenous fistula with buttonhole in hemodialysis patients

Percutaneous transluminal balloon angioplasty in stenosis of native hemodialysis arteriovenous fistulas: technical success and analysis of factors affecting postprocedural fistula patency.

Differential expression of serum TM, PAF, and CD62P in patients with autologous arteriovenous fistula and the correlation with vascular access function

Patency Rate of Autogenous Arteriovenous Fistula after Repairment in the Patients with Late Fistula Dysfunction/faliure

Ultrasound Evaluation of Balloon Angioplasty for the Treatment of Autogenous Arteriovenous Fistula Anastomotic Stenosis: Ultrasound evaluation of PTA for AVF anastomotic stenosis

Endovascular salvage of arteriovenous fistula malfunction in hemodialysis patients

Application of interventional catheterization procedure in arteriovenous fistula dysfunction

Analysis of Risk Factors for Autogenous Arterio-venous Fistulas Thrombosis in Chronic Hemodialysis Patients

The Effect of Endovascular Management of Arteriovenous Fistulae the Stenosis A Review of Local Experience: A Review of Local Experience